371 related articles for article (PubMed ID: 32234710)
1. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
[TBL] [Abstract][Full Text] [Related]
2. miR-1225-5p Functions as a Tumor Suppressor in Osteosarcoma by Targeting Sox9.
Zhang W; Wei L; Sheng W; Kang B; Wang D; Zeng H
DNA Cell Biol; 2020 Jan; 39(1):78-91. PubMed ID: 31765229
[TBL] [Abstract][Full Text] [Related]
3. Local anesthetic levobupivacaine inhibits stemness of osteosarcoma cells by epigenetically repressing MAFB though reducing KAT5 expression.
Wang Z; Song Y; Zhang H; Yang Y; Zhang S; Wang W
Aging (Albany NY); 2022 Mar; 14(6):2793-2804. PubMed ID: 35333774
[TBL] [Abstract][Full Text] [Related]
4. Circ_0051079 functions as an oncogenic regulator in osteosarcoma by leading to MAFB expression upregulation by competitively interacting with miR-1286.
Huang Z; Chen P; Jia R; Liu Y
J Orthop Surg Res; 2022 Sep; 17(1):428. PubMed ID: 36153605
[TBL] [Abstract][Full Text] [Related]
5. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
[TBL] [Abstract][Full Text] [Related]
6. Transcription Factor SOX9 Promotes Osteosarcoma Cell Growth by Repressing Claudin-8 Expression.
Qi J; Yang Y; Hao P; Xu J
Tohoku J Exp Med; 2017 Jan; 241(1):55-63. PubMed ID: 28123165
[TBL] [Abstract][Full Text] [Related]
7. SOX9-activated FARSA-AS1 predetermines cell growth, stemness, and metastasis in colorectal cancer through upregulating FARSA and SOX9.
Zhou T; Wu L; Ma N; Tang F; Yu Z; Jiang Z; Li Y; Zong Z; Hu K
Cell Death Dis; 2020 Dec; 11(12):1071. PubMed ID: 33318478
[TBL] [Abstract][Full Text] [Related]
8. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
10. Involvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.
Tsuchiya H; Oura S
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757260
[TBL] [Abstract][Full Text] [Related]
11. Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP.
Cheng L; Wu B; Zhang L; Bian E; An R; Yu S; Liu W; Xiong Z
Cell Signal; 2020 Jan; 65():109460. PubMed ID: 31678253
[TBL] [Abstract][Full Text] [Related]
12. miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9.
Wang WT; Qi Q; Zhao P; Li CY; Yin XY; Yan RB
Biomed Pharmacother; 2018 Nov; 107():1763-1769. PubMed ID: 30257395
[TBL] [Abstract][Full Text] [Related]
13. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis.
Zhu H; Tang J; Tang M; Cai H
Diagn Pathol; 2013 Nov; 8():183. PubMed ID: 24188461
[TBL] [Abstract][Full Text] [Related]
16. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
[TBL] [Abstract][Full Text] [Related]
17. SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition.
Wang W; Chen D; Zhu K
J Exp Clin Cancer Res; 2018 Feb; 37(1):37. PubMed ID: 29475441
[TBL] [Abstract][Full Text] [Related]
18. miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.
Ji Q; Xu X; Song Q; Xu Y; Tai Y; Goodman SB; Bi W; Xu M; Jiao S; Maloney WJ; Wang Y
Mol Ther; 2018 May; 26(5):1299-1312. PubMed ID: 29628305
[TBL] [Abstract][Full Text] [Related]
19. SUMOylated MAFB promotes colorectal cancer tumorigenesis.
Yang LS; Zhang XJ; Xie YY; Sun XJ; Zhao R; Huang QH
Oncotarget; 2016 Dec; 7(50):83488-83501. PubMed ID: 27829226
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
Chen F; Mo J; Zhang L
Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
